To assess the change in rates of recurrence-free survival (RFS) and progression-free survival (PFS) based on duration of survival without recurrence or progression among patients with intermediate-risk (IR) non-muscle invasive bladder cancer (NMIBC), and to examine predictive factors of recurrence at different time points, we examined conditional RFS and PFS.